A recent Indianapolis Business Journal (IBJ) article takes a look back at 20 years of success for BioCrossroads, the life sciences initiative of the Central Indiana Corporate Partnership (CICP).
In two decades, BioCrossroads has assisted more than 500 startup companies, raised more than $600 million of market capital and helped attract thousands of jobs.
In 2022, data shows that Indiana leads the United States in pharmaceutical sales and is one of three top states for exports of all life sciences products – pharmaceuticals, medical devices, and agbiosciences, while providing an $80 billion economic impact.
In 2023, BioCrossroads announced that President and CEO Patty Martin would step down to pursue other ventures. “I think it’s just a logical time right now to take a couple of months and really take a good hard, informed look at where we are overall,” said Dan Peterson, BioCrossroads chair and vice president industry and government affairs for Cook Group. “What are we doing, given all the opportunities, and the changes in the field overall? Or what aren’t we doing that we might need to do? [READ MORE]
(Sources: IBJ and BioCrossroads)
